Good morning, and welcome to Ocugen's Webcast to discuss the Top Line 12-month Results from Phase II ArMaDa Clinical Trial Evaluating OCU410 for Geographic Atrophy or GA Secondary to Dry Age-related ...
Antiviral drug discovery is a critical and rapidly evolving area of biomedical research, driven by the urgent need to combat existing and emerging viral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results